Literature DB >> 12269452

Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer.

Issam Raad1, Jeffrey Tarrand, Hend Hanna, Maher Albitar, Erle Janssen, Maha Boktour, Gerald Bodey, Masoud Mardani, Ray Hachem, Dimitrios Kontoyiannis, Estella Whimbey, Kenneth Rolston.   

Abstract

OBJECTIVE: To investigate the epidemiology and environmental sources of Fusarium infections in patients with cancer.
DESIGN: Retrospective case-control study conducted following surveillance environmental cultures and DNA analysis of isolated organisms.
SETTING: A tertiary-care, university cancer center.
METHODS: In 1996 and 1997, environmental cultures were performed on air samples and water systems. A retrospective chart review was performed for 70 patients with cancer identified with fusariosis between 1987 and 1997. Patients with fusariosis were compared with 49 uninfected control patients who occupied hospital rooms with positive environmental cultures for Fusarium. With the use of random amplification of polymorphic DNA, organisms isolated from infected patients were compared with environmental organisms.
RESULTS: Most of the patients with Fusarium (40, 57%) were infected on or within 3 days of admission, indicating community rather than nosocomial acquisition. Patients were comparable in terms of underlying immunocompromised status to 49 uninfected control patients. However, the duration from admission to infection in the patients with fusariosis tended to be shorter than the duration from admission to discharge in the exposed control patients (P = .06). Water cultured from the hospital tanks and from sinks and water fountains was negative for Fusarium. With the use of polymerase chain reaction, environmental isolates did not match clinical ones. Quantitative air sampling showed that the quantitative outdoor Fusarium levels were eightfold higher than the indoor levels. During the rainy summer season, outdoor air concentrations of Fusarium were at their highest, coinciding with the peak incidence of fusariosis at our center.
CONCLUSION: The most likely source of fusariosis was the external environment rather than nosocomial sources, such as water.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269452     DOI: 10.1086/502102

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  21 in total

1.  Widespread occurrence of diverse human pathogenic types of the fungus Fusarium detected in plumbing drains.

Authors:  Dylan P G Short; Kerry O'Donnell; Ning Zhang; Jean H Juba; David M Geiser
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

2.  Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates.

Authors:  M Healy; K Reece; D Walton; J Huong; S Frye; I I Raad; D P Kontoyiannis
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors:  Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

Review 4.  Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Zahida Bhatti; Aasma Shaukat; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

5.  Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.

Authors:  A B A Teixeira; M L Moretti; P Trabasso; A von Nowakonski; F H Aoki; A C Vigorito; M Miyaji; K Nishimura; H Taguchi; A Z Schreiber
Journal:  Mycopathologia       Date:  2005-11       Impact factor: 2.574

Review 6.  Freshwater Fungal Infections.

Authors:  Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2017-01-31

7.  Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel.

Authors:  Ran Nir-Paz; Jacob Strahilevitz; Mervyn Shapiro; Nathan Keller; Anna Goldschmied-Reouven; Oded Yarden; Colin Block; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 8.  Changing epidemiology of rare mould infections: implications for therapy.

Authors:  Anurag N Malani; Carol A Kauffman
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients.

Authors:  Kimberly Partridge-Hinckley; Gale M Liddell; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2009-12       Impact factor: 2.574

Review 10.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.